{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:59:56Z","timestamp":1768013996662,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00436-025-08576-z","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T21:04:36Z","timestamp":1764795876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Furamidine, a methyltransferase inhibitor, is a potential anti-Babesia spp. chemotherapeutic"],"prefix":"10.1007","volume":"124","author":[{"given":"Qindong","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaiyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongge","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiquan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"8576_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vetpar.2018.03.001","volume":"254","author":"G Baneth","year":"2018","unstructured":"Baneth G (2018) Antiprotozoal treatment of canine babesiosis. Vet Parasitol 254:58\u201363. https:\/\/doi.org\/10.1016\/j.vetpar.2018.03.001","journal-title":"Vet Parasitol"},{"issue":"11","key":"8576_CR2","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/cmdc.201100265","volume":"6","author":"O Berger","year":"2011","unstructured":"Berger O et al (2011) Synthesis and antimalarial activities of a diverse set of triazole-containing furamidine analogues. ChemMedChem 6(11):2094\u20132108. https:\/\/doi.org\/10.1002\/cmdc.201100265","journal-title":"ChemMedChem"},{"key":"8576_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.phrs.2015.10.005","volume":"102","author":"GL da Silva Oliveira","year":"2015","unstructured":"da Silva Oliveira GL, de Freitas RM (2015) Diminazene aceturate\u2013an antiparasitic drug of antiquity: advances in pharmacology & therapeutics. Pharmacol Res 102:138\u2013157. https:\/\/doi.org\/10.1016\/j.phrs.2015.10.005","journal-title":"Pharmacol Res"},{"issue":"1","key":"8576_CR4","doi-asserted-by":"publisher","first-page":"e000560","DOI":"10.1136\/bmjdrc-2018-000560","volume":"6","author":"I Dirnena-Fusini","year":"2018","unstructured":"Dirnena-Fusini I, \u00c5m MK, Fougner AL, Carlsen SM, Christiansen SC (2018) Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial. BMJ Open Diabetes Res Care 6(1):e000560. https:\/\/doi.org\/10.1136\/bmjdrc-2018-000560","journal-title":"BMJ Open Diabetes Res Care"},{"key":"8576_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","volume":"45","author":"DC Drummond","year":"2005","unstructured":"Drummond DC, Noble CO, Kirpotin DB, Guo ZX, Scott GK, Benz CC (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol 45:495\u2013528. https:\/\/doi.org\/10.1146\/annurev.pharmtox.45.120403.095825","journal-title":"Annu Rev Pharmacol"},{"issue":"1","key":"8576_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13287-025-04409-z","volume":"16","author":"D Du","year":"2025","unstructured":"Du D et al (2025) PRMT1 inhibition enhances the cardioprotective effect of adipose-derived mesenchymal stem cells against myocardial infarction through RUNX1. Stem Cell Res Ther 16(1):279. https:\/\/doi.org\/10.1186\/s13287-025-04409-z","journal-title":"Stem Cell Res Ther"},{"key":"8576_CR7","doi-asserted-by":"publisher","first-page":"1278451","DOI":"10.3389\/fphar.2023.1278451","volume":"14","author":"SAE El-Sayed","year":"2023","unstructured":"El-Sayed SAE et al (2023) Antiparasitic activity of FLLL-32 against four Babesia species, B. bovis, B. bigemina, B. divergens and B. caballi, and one Theileria species, Theileria equi in vitro, and Babesia microti in mice. Front Pharmacol 14:1278451. https:\/\/doi.org\/10.3389\/fphar.2023.1278451","journal-title":"Front Pharmacol"},{"issue":"12","key":"8576_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s1473-3099(15)00177-2","volume":"15","author":"LQ Fang","year":"2015","unstructured":"Fang LQ et al (2015) Emerging tick-borne infections in mainland China: an increasing public health threat. Lancet Infect Dis 15(12):1467\u20131479. https:\/\/doi.org\/10.1016\/s1473-3099(15)00177-2","journal-title":"Lancet Infect Dis"},{"key":"8576_CR9","doi-asserted-by":"publisher","unstructured":"Fang T, Ben Mamoun C (2024) Babesia duncani, a model organism for investigating intraerythrocytic parasitism and novel anti-parasitic therapeutic strategies. J Infect Dis https:\/\/doi.org\/10.1093\/infdis\/jiae191","DOI":"10.1093\/infdis\/jiae191"},{"issue":"12","key":"8576_CR10","doi-asserted-by":"publisher","first-page":"e1010056","DOI":"10.1371\/journal.ppat.1010056","volume":"17","author":"K Fleck","year":"2021","unstructured":"Fleck K, Nitz M, Jeffers V (2021) \u201cReading\u201d a new chapter in protozoan parasite transcriptional regulation. PLoS Pathog 17(12):e1010056. https:\/\/doi.org\/10.1371\/journal.ppat.1010056","journal-title":"PLoS Pathog"},{"issue":"2","key":"8576_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.inf.0000195438.09628.b0","volume":"25","author":"LM Fox","year":"2006","unstructured":"Fox LM et al (2006) Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J 25(2):169\u2013173. https:\/\/doi.org\/10.1097\/01.inf.0000195438.09628.b0","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"8576_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.tvjl.2012.10.025","volume":"196","author":"JF Grause","year":"2013","unstructured":"Grause JF, Ueti MW, Nelson JT, Knowles DP, Kappmeyer LS, Bunn TO (2013) Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. Vet J 196(3):541\u2013546. https:\/\/doi.org\/10.1016\/j.tvjl.2012.10.025","journal-title":"Vet J"},{"issue":"4","key":"8576_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.exppara.2009.05.001","volume":"122","author":"GQ Guan","year":"2009","unstructured":"Guan GQ et al (2009) A new ovine Babesia species transmitted by Hyalomma anatolicum. Exp Parasitol 122(4):261\u2013267. https:\/\/doi.org\/10.1016\/j.exppara.2009.05.001","journal-title":"Exp Parasitol"},{"issue":"1\u20132","key":"8576_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vetpar.2010.02.006","volume":"170","author":"G Guan","year":"2010","unstructured":"Guan G, Moreau E, Brisseau N, Luo J, Yin H, Chauvin A (2010) Determination of erythrocyte susceptibility of Chinese sheep (Tan mutton breed) and French sheep (Vend\u00e9en breed) to Babesia sp. BQ1 (Lintan) by in vitro culture. Vet Parasitol 170(1\u20132):37\u201343. https:\/\/doi.org\/10.1016\/j.vetpar.2010.02.006","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"8576_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.vetpar.2012.02.006","volume":"187","author":"GQ Guan","year":"2012","unstructured":"Guan GQ et al (2012a) Continuous in vitro cultivation of a recently identified Babesia that infects small ruminants in China. Vet Parasitol 187(3\u20134):371\u2013378. https:\/\/doi.org\/10.1016\/j.vetpar.2012.02.006","journal-title":"Vet Parasitol"},{"issue":"4","key":"8576_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.parint.2012.04.004","volume":"61","author":"GQ Guan","year":"2012","unstructured":"Guan GQ et al (2012b) A recently identified ovine Babesia in China: serology and sero-epidemiology. Parasitol Int 61(4):532\u2013537. https:\/\/doi.org\/10.1016\/j.parint.2012.04.004","journal-title":"Parasitol Int"},{"issue":"1","key":"8576_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s13071-016-1846-1","volume":"9","author":"GQ Guan","year":"2016","unstructured":"Guan GQ et al (2016) Genomic resources for a unique, low-virulence Babesia taxon from China. Parasite Vector 9(1):564. https:\/\/doi.org\/10.1186\/s13071-016-1846-1","journal-title":"Parasite Vector"},{"key":"8576_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10091165","author":"A Hildebrandt","year":"2021","unstructured":"Hildebrandt A, Zintl A, Montero E, Hunfeld KP, Gray J (2021) Human babesiosis in Europe. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10091165","journal-title":"Pathogens"},{"issue":"3","key":"8576_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/cmr.13.3.451","volume":"13","author":"MJ Homer","year":"2000","unstructured":"Homer MJ, Aguilar-Delfin I, Telford SR 3rd, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13(3):451\u2013469. https:\/\/doi.org\/10.1128\/cmr.13.3.451","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"8576_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/22221751.2019.1622997","volume":"8","author":"SH Hong","year":"2019","unstructured":"Hong SH et al (2019) Detection and characterization of an emerging type of Babesia sp. similar to Babesia motasi for the first case of human babesiosis and ticks in Korea. Emerg Microbes Infect 8(1):869\u2013878. https:\/\/doi.org\/10.1080\/22221751.2019.1622997","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"8576_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40249-023-01111-1","volume":"12","author":"L Huang","year":"2023","unstructured":"Huang L et al (2023) Successful treatment with doxycycline monotherapy for human infection with Babesia venatorum (Babesiidae, Sporozoa) in China: a case report and proposal for a clinical regimen. Infect Dis Poverty 12(1):67. https:\/\/doi.org\/10.1186\/s40249-023-01111-1","journal-title":"Infect Dis Poverty"},{"issue":"10","key":"8576_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/cbic.201800718","volume":"20","author":"CA Jabeena","year":"2019","unstructured":"Jabeena CA, Rajavelu A (2019) Epigenetic players of chromatin structure regulation in Plasmodium falciparum. ChemBioChem 20(10):1225\u20131230. https:\/\/doi.org\/10.1002\/cbic.201800718","journal-title":"ChemBioChem"},{"issue":"7","key":"8576_CR23","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/ciy212","volume":"67","author":"N Jia","year":"2018","unstructured":"Jia N et al (2018) Human babesiosis caused by a Babesia crassa-like pathogen: a case series. Clin Infect Dis 67(7):1110\u20131119. https:\/\/doi.org\/10.1093\/cid\/ciy212","journal-title":"Clin Infect Dis"},{"issue":"8","key":"8576_CR24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3201\/eid1808.110988","volume":"18","author":"JT Joseph","year":"2012","unstructured":"Joseph JT et al (2012) Vertical transmission of Babesia microti, United States. Emerg Infect Dis 18(8):1318\u20131321. https:\/\/doi.org\/10.3201\/eid1808.110988","journal-title":"Emerg Infect Dis"},{"issue":"12\u201313","key":"8576_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/s0020-7519(00)00137-5","volume":"30","author":"AM Kjemtrup","year":"2000","unstructured":"Kjemtrup AM, Conrad PA (2000) Human babesiosis: an emerging tick-borne disease. Int J Parasitol 30(12\u201313):1323\u20131337. https:\/\/doi.org\/10.1016\/s0020-7519(00)00137-5","journal-title":"Int J Parasitol"},{"issue":"2","key":"8576_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpara.2018.11.007","volume":"49","author":"PJ Krause","year":"2019","unstructured":"Krause PJ (2019) Human babesiosis. Int J Parasitol 49(2):165\u2013174. https:\/\/doi.org\/10.1016\/j.ijpara.2018.11.007","journal-title":"Int J Parasitol"},{"key":"8576_CR27","doi-asserted-by":"publisher","unstructured":"Kumar A, O\u2019Bryan J, Krause PJ (2021) The global emergence of human babesiosis. Pathogens (Basel, Switzerland) 10(11) https:\/\/doi.org\/10.3390\/pathogens10111447","DOI":"10.3390\/pathogens10111447"},{"issue":"10","key":"8576_CR28","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","volume":"6","author":"YX Li","year":"2016","unstructured":"Li YX, Seto E (2016) HDACs and HDAC inhibitors in cancer development and therapy. CSH Perspect Med 6(10):a026831. https:\/\/doi.org\/10.1101\/cshperspect.a026831","journal-title":"CSH Perspect Med"},{"issue":"4","key":"8576_CR29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3201\/eid2604.200025","volume":"26","author":"PL Lim","year":"2020","unstructured":"Lim PL, Chavatte JM, Vasoo S, Yang J (2020) Imported Human Babesiosis, Singapore, 2018. Emerg Infect Dis 26(4):826\u2013828. https:\/\/doi.org\/10.3201\/eid2604.200025","journal-title":"Emerg Infect Dis"},{"issue":"41","key":"8576_CR30","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1073\/pnas.1205414109","volume":"109","author":"NA Malmquist","year":"2012","unstructured":"Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ (2012) Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Proc Natl Acad Sci U S A 109(41):16708\u201316713. https:\/\/doi.org\/10.1073\/pnas.1205414109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8576_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13071-023-05817-x","volume":"16","author":"E Montero","year":"2023","unstructured":"Montero E et al (2023) Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain. Parasit Vectors 16(1):195. https:\/\/doi.org\/10.1186\/s13071-023-05817-x","journal-title":"Parasit Vectors"},{"issue":"10","key":"8576_CR32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2174\/092986712799828355","volume":"19","author":"J Mosqueda","year":"2012","unstructured":"Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ (2012) Current advances in detection and treatment of babesiosis. Curr Med Chem 19(10):1504\u20131518. https:\/\/doi.org\/10.2174\/092986712799828355","journal-title":"Curr Med Chem"},{"issue":"7","key":"8576_CR33","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1128\/aac.01482-10","volume":"55","author":"A Nehrbass-Stuedli","year":"2011","unstructured":"Nehrbass-Stuedli A, Boykin D, Tidwell RR, Brun R (2011) Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo. Antimicrob Agents Chemother 55(7):3439\u20133445. https:\/\/doi.org\/10.1128\/aac.01482-10","journal-title":"Antimicrob Agents Chemother"},{"key":"8576_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205087","author":"CJ Ngwa","year":"2019","unstructured":"Ngwa CJ, Kiesow MJ, Orchard LM, Farrukh A, Llin\u00e1s M, Pradel G (2019) The G9a histone methyltransferase inhibitor BIX-01294 modulates gene expression during Plasmodium falciparum gametocyte development and transmission. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20205087","journal-title":"Int J Mol Sci"},{"key":"8576_CR35","doi-asserted-by":"publisher","first-page":"109138","DOI":"10.1016\/j.vetpar.2020.109138","volume":"282","author":"CF Obi","year":"2020","unstructured":"Obi CF et al (2020) Azithromycin and diminazene aceturate combination therapy in experimental multidrug-resistant Trypanosoma brucei brucei infection in albino rats. Vet Parasitol 282:109138. https:\/\/doi.org\/10.1016\/j.vetpar.2020.109138","journal-title":"Vet Parasitol"},{"issue":"4","key":"8576_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40588-015-0025-z","volume":"2","author":"RL Ord","year":"2015","unstructured":"Ord RL, Lobo CA (2015) Human babesiosis: pathogens, prevalence, diagnosis, and treatment. Curr Clin Microbiol 2(4):173\u2013181. https:\/\/doi.org\/10.1007\/s40588-015-0025-z","journal-title":"Curr Clin Microbiol"},{"issue":"11","key":"8576_CR37","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3201\/eid2411.170512","volume":"24","author":"G Peniche-Lara","year":"2018","unstructured":"Peniche-Lara G, Balmaceda L, Perez-Osorio C, Munoz-Zanzi C (2018) Human babesiosis, Yucat\u00e1n State, Mexico, 2015. Emerg Infect Dis 24(11):2061\u20132062. https:\/\/doi.org\/10.3201\/eid2411.170512","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"8576_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.7326\/0003-4819-119-4-199308150-00006","volume":"119","author":"RE Quick","year":"1993","unstructured":"Quick RE et al (1993) Babesiosis in Washington state: a new species of Babesia? Ann Intern Med 119(4):284\u2013290. https:\/\/doi.org\/10.7326\/0003-4819-119-4-199308150-00006","journal-title":"Ann Intern Med"},{"issue":"2","key":"8576_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/aac.46.2.487-499.2002","volume":"46","author":"JC Rodrigues","year":"2002","unstructured":"Rodrigues JC, Attias M, Rodriguez C, Urbina JA, Souza W (2002) Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob Agents Chemother 46(2):487\u2013499. https:\/\/doi.org\/10.1128\/aac.46.2.487-499.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"8576_CR40","doi-asserted-by":"publisher","first-page":"e1007066","DOI":"10.1371\/journal.ppat.1007066","volume":"14","author":"D Roquis","year":"2018","unstructured":"Roquis D et al (2018) Histone methylation changes are required for life cycle progression in the human parasite Schistosoma mansoni. PLoS Pathog 14(5):e1007066. https:\/\/doi.org\/10.1371\/journal.ppat.1007066","journal-title":"PLoS Pathog"},{"issue":"5","key":"8576_CR41","doi-asserted-by":"publisher","first-page":"e01079","DOI":"10.1128\/mBio.01079-20","volume":"11","author":"S Saha","year":"2020","unstructured":"Saha S (2020) Histone modifications and other facets of epigenetic regulation in trypanosomatids: leaving their mark. Mbio 11(5):e01079-e1120. https:\/\/doi.org\/10.1128\/mBio.01079-20","journal-title":"Mbio"},{"issue":"1","key":"8576_CR42","first-page":"11","volume":"9","author":"Z Skrabalo","year":"1957","unstructured":"Skrabalo Z, Deanovic Z (1957) Piroplasmosis in man; report of a case. Doc Med Geogr Trop 9(1):11\u201316","journal-title":"Doc Med Geogr Trop"},{"issue":"3","key":"8576_CR43","doi-asserted-by":"publisher","first-page":"188865","DOI":"10.1016\/j.bbcan.2023.188865","volume":"1878","author":"NC Sutopo","year":"2023","unstructured":"Sutopo NC, Kim JH, Cho JY (2023) Role of histone methylation in skin cancers: histone methylation-modifying enzymes as a new class of targets for skin cancer treatment. Biochim Biophys Acta (BBA) 1878(3):188865. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188865","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"1\u20133","key":"8576_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0304-4017(94)03107-8","volume":"57","author":"G Uilenberg","year":"1995","unstructured":"Uilenberg G (1995) International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol 57(1\u20133):19\u201341. https:\/\/doi.org\/10.1016\/0304-4017(94)03107-8","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"8576_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vetpar.2006.01.035","volume":"138","author":"G Uilenberg","year":"2006","unstructured":"Uilenberg G (2006) Babesia\u2013a historical overview. Vet Parasitol 138(1\u20132):3\u201310. https:\/\/doi.org\/10.1016\/j.vetpar.2006.01.035","journal-title":"Vet Parasitol"},{"issue":"10","key":"8576_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.mpaic.2020.07.001","volume":"21","author":"R Vaja","year":"2020","unstructured":"Vaja R, Rana M (2020) Drugs and the liver. Anaesth Intensive Care Med 21(10):517\u2013523. https:\/\/doi.org\/10.1016\/j.mpaic.2020.07.001","journal-title":"Anaesth Intensive Care Med"},{"issue":"8","key":"8576_CR47","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1021\/acsinfecdis.0c00853","volume":"7","author":"LN Vanheer","year":"2021","unstructured":"Vanheer LN, Kafsack BFC (2021) Activity comparison of epigenetic modulators against the hemoprotozoan parasites Babesia divergens and Plasmodium falciparum. ACS Infect Dis 7(8):2277\u20132284. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00853","journal-title":"ACS Infect Dis"},{"issue":"25","key":"8576_CR48","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMra1202018","volume":"366","author":"E Vannier","year":"2012","unstructured":"Vannier E, Krause PJ (2012) Human babesiosis. N Engl J Med 366(25):2397\u20132407. https:\/\/doi.org\/10.1056\/NEJMra1202018","journal-title":"N Engl J Med"},{"issue":"2","key":"8576_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.idc.2015.02.008","volume":"29","author":"EG Vannier","year":"2015","unstructured":"Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ (2015) Babesiosis. Infect Dis Clin North Am 29(2):357\u2013370. https:\/\/doi.org\/10.1016\/j.idc.2015.02.008","journal-title":"Infect Dis Clin North Am"},{"key":"8576_CR50","doi-asserted-by":"publisher","unstructured":"Verma SK et al (2012) Discovery and synthesis of highly potent and selective small molecule inhibitors of the histone methyltransferase EZH2. Cancer Res 72 https:\/\/doi.org\/10.1158\/1538-7445.Am2012-2939","DOI":"10.1158\/1538-7445.Am2012-2939"},{"issue":"4","key":"8576_CR51","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1021\/acsinfecdis.4c00143","volume":"10","author":"P Vydyam","year":"2024","unstructured":"Vydyam P et al (2024a) Effectiveness of two new endochin-like quinolones, ELQ-596 and ELQ-650, in experimental mouse models of human babesiosis. ACS Infect Dis 10(4):1405\u20131413. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00143","journal-title":"ACS Infect Dis"},{"issue":"1","key":"8576_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/infdis\/jiad315","volume":"229","author":"P Vydyam","year":"2024","unstructured":"Vydyam P et al (2024b) Tafenoquine-atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human babesiosis. J Infect Dis 229(1):161\u2013172. https:\/\/doi.org\/10.1093\/infdis\/jiad315","journal-title":"J Infect Dis"},{"issue":"1","key":"8576_CR53","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/22221751.2019.1635431","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019) Babesia divergens in human in Gansu province, China. Emerg Microbes Infect 8(1):959\u2013961. https:\/\/doi.org\/10.1080\/22221751.2019.1635431","journal-title":"Emerg Microbes Infect"},{"issue":"10","key":"8576_CR54","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1128\/aac.00225-09","volume":"53","author":"T Wenzler","year":"2009","unstructured":"Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, Brun R (2009) New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 53(10):4185\u20134192. https:\/\/doi.org\/10.1128\/aac.00225-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"8576_CR55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/cac2.12313","volume":"42","author":"Y Xu","year":"2022","unstructured":"Xu Y et al (2022) Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials. Cancer Commun (Lond) 42(6):493\u2013516. https:\/\/doi.org\/10.1002\/cac2.12313","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"8576_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3201\/eid2903.220888","volume":"29","author":"J Yao","year":"2023","unstructured":"Yao J et al (2023) Babesia microti causing intravascular hemolysis in immunocompetent child, China. Emerg Infect Dis 29(3):667\u2013669. https:\/\/doi.org\/10.3201\/eid2903.220888","journal-title":"Emerg Infect Dis"},{"key":"8576_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.actatropica.2017.02.007","volume":"170","author":"AA Zuma","year":"2017","unstructured":"Zuma AA, Santos JO, Mendes I, de Souza W, Machado CR, Motta MCM (2017) Chaetocin-A histone methyltransferase inhibitor-impairs proliferation, arrests cell cycle and induces nucleolar disassembly in Trypanosoma cruzi. Acta Trop 170:149\u2013160. https:\/\/doi.org\/10.1016\/j.actatropica.2017.02.007","journal-title":"Acta Trop"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-025-08576-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:02:34Z","timestamp":1767988954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-025-08576-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["8576"],"URL":"https:\/\/doi.org\/10.1007\/s00436-025-08576-z","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Animal Ethics Committee of the Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (permit No. LVRIAEC-2022\u2013001). All animal experiments were performed in accordance with the Animal Ethics Procedures and Guidelines of the People\u2019s Republic of China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"149"}}